GeneDx Holdings Corp. (WGS), through its subsidiaries, provides genomics-related diagnostic and information services.

The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights.

It provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening.

GeneDx Holdings Corp. was founded in 2017 and is headquartered in Stamford, Connecticut.